This comprehensive case study explores Kymanox’s approach to Pre-Approval Inspection (PAI) readiness through mock inspections, personnel training, and systematic remediation planning. Our team of Subject Matter Experts (SMEs) collaborated closely with pharmaceutical stakeholders to implement measurable improvements across inspection preparation, compliance gap identification, Corrective and Preventive Action (CAPA) development, and regulatory readiness ensuring successful FDA PAIs and product authorization.
CHALLENGE
SOLUTION
RESULTS
- Pharmaceutical manufacturer required comprehensive assessment of FDA pre-approval materials and inspection preparation ensuring regulatory compliance and approval readiness.
- Mock inspection execution essential identifying potential compliance gaps, procedural weaknesses, and documentation deficiencies before actual FDA PAI.
- Remediation planning development and implementation critical addressing identified non-conformances and strengthening quality systems prior to regulatory scrutiny.
- Quality and Regulatory Affairs personnel training needed ensuring confident, knowledgeable responses to inspector questions and demonstrating compliance culture.
- Conducted comprehensive training programs for Quality and Regulatory Affairs personnel preparing cross-functional teams for scheduled FDA PAIs.
- Drafted detailed inspection agendas mirroring FDA PAI protocols, conducted rigorous on-site mock inspections, and issued comprehensive inspection reports.
- Delivered real-time feedback and coaching during mock inspection process providing immediate guidance on responses, documentation presentation, and inspector engagement.
- Identified specific CAPAs addressing compliance gaps, documentation deficiencies, and procedural weaknesses discovered during assessment.
- Executed effective remediation plans implementing systemic improvements, updating Standard Operating Procedures (SOPs), and enhancing documentation quality.
- Validated CAPA effectiveness through follow-up assessments ensuring sustainable compliance improvements and inspection readiness.
- Produced detailed comprehensive reports highlighting compliance gaps, documentation deficiencies, and areas requiring improvement with actionable recommendations.
- Successfully reviewed and validated CAPA plans ensuring timely resolution of identified non-conformances prior to actual FDA inspection.
- Achieved successful FDA pre-approval inspections resulting in product market authorization approval and commercial launch clearance.
- Strengthened organizational inspection readiness and compliance culture through comprehensive training and realistic mock inspection experience.
- Established sustainable quality system improvements supporting ongoing regulatory compliance and future inspection success.